Blend Uniformity Guidance Withdrawn In Face Of PQRI Recommendations
This article was originally published in The Tan Sheet
Executive Summary
FDA has withdrawn a draft guidance that established in-process acceptance criteria related to blend uniformity analysis for certain drugs